x.com· @ · X·· 2026-04-23Score60
Reading
Immunotherapy: CAR-T in solid tumors, mRNA vaccines, TCR-T
CAR-PRISM’s universal MRD negativity happened in a window of healthier T cells and lower burden; solid tumors do not have that window yet.
Body
Janos Tanyi, MD, PhD, shared new #CART research at #AACR26 this week. The first of its kind Phase I clinical trial uses a KIR-CAR modeled after natural killer cells and is designed to limit T cell exhaustion. https://t.co/3zqqpRNYqh
Heat 1 · 1 like · 0 replies · 0 reposts
Source: x.com · x.com